Longboard Pharmaceuticals, Inc. (LBPH) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2024-12-02

Longboard Pharmaceuticals, Inc. (LBPH) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every LBPH SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Longboard Pharmaceuticals, Inc. (LBPH)

SEC CIK	0001832168

Recent LBPH Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2024-12-02	Lind Kevin Robert	President and CEO	J — Other acquisition / disposition	363.7K	$60.00	$21.82M	SEC
2024-12-02	Kaye Randall	Executive Vice President & CMO	J — Other acquisition / disposition	30.6K	$60.00	$1.83M	SEC
2024-11-19	Kaye Randall	CMO	M — Option exercise	30.6K	$6.00	$183K	SEC
2024-11-13	Lind Kevin Robert	CEO	G — Bona-fide gift	80.0K	$0.00	—	SEC
2024-11-13	Lind Kevin Robert	CEO	M — Option exercise	12.8K	$3.12	$40K	SEC
2024-10-15	Kaye Randall	CMO	S — Open-market sale [10b5-1]	16.7K	$59.03	$984K	SEC
2024-10-15	Kaye Randall	CMO	M — Option exercise [10b5-1]	16.7K	$4.35	$73K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Longboard Pharmaceuticals, Inc. (LBPH). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2024-12-02 — SCHNEIDER PHILLIP M (Insider)
2024-12-02 — Roberts Brandi (Executive VP and CFO)
2024-12-02 — SEKHRI PAUL J (Insider)
2024-12-02 — Kaye Randall (Executive Vice President & CMO)
2024-12-02 — Aurentz Vincent (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in LBPH insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

LBPH Insider Trading — FAQ

What is the latest insider trade for LBPH?: Longboard Pharmaceuticals, Inc. (LBPH) had 0 insider filings in the last 90 days, with the most recent on 2024-12-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying LBPH stock?: 0 insider purchases of LBPH were filed in the last 90 days.
How many insiders are selling LBPH stock?: 0 insider sales of LBPH were filed in the last 90 days.
Where can I see LBPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every LBPH SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live LBPH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.